Arkolith/Insider Trading/ERNA/Form 4

Cherington Charles

10% OwnerEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Dec 20, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 14, 2023Buy(P)2.3M$0.13$300K0
Dec 14, 2023Buy(P)0———
Dec 14, 2023Buy(P)524K——0
Dec 14, 2023Expiration(H)524K——524K
Dec 14, 2023Buy(P)3.1M$3000000.00$9.4T3.1M
Dec 14, 2023Expiration(H)2.3M——2.3M

Transaction Codes

P
Open-market purchase
H
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-127551) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML